Skip to main content
Erschienen in: World Journal of Urology 11/2023

09.09.2023 | Original Article

Gut microbiome in men with chronic prostatitis/chronic pelvic pain syndrome: profiling and its predictive significance

verfasst von: Shuai Wang, Maolin Zang, Xiaohui Yang, Linchen Lv, Lipeng Chen, Jianfeng Cui, Yaxiao Liu, Yangyang Xia, Nan Zhou, Zizhuo Yang, Yan Li, Benkang Shi

Erschienen in: World Journal of Urology | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the difference in gut microbiome composition between patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and healthy controls, and to assess the potential of gut microbiota as predictive markers for CP/CPPS risk.

Methods

The present study included 41 CP/CPPS patients and 43 healthy controls in China. Fecal specimen data were obtained and analysed using 16S rRNA gene sequencing. Alpha and beta-diversity indices, relative microbiome abundances, cluster analysis, and linear discriminant analysis effect size (LEfSe) were employed. Microbial biomarkers were selected for the development of a diagnostic classification model, and the functional prediction was conducted using PICRUSt2.

Results

Alpha-diversity measures revealed no statistically significant difference in bacterial community structure between CP/CPPS patients and controls. However, significant differences were observed in the relative abundances of several bacterial genera. Beta-diversity analysis revealed a distinct separation between the two groups. Significant inter-group differences were noted at various taxonomic levels, with specific bacterial genera being significantly different in abundance. The LEfSe analysis indicated that three bacterial species were highly representative and seven bacterial species were low in CP/CPPS patients as compared to the control group. A diagnostic model for CP/CPPS based on microbial biomarkers exhibited good performance. PICRUSt2 functional profiling indicated significant differences in the development and regeneration pathway.

Conclusion

Significant differences in the gut microbiome composition were found between groups. The study provided a novel diagnostic model for CP/CPPS based on microbiota, presenting promising potential for future therapeutic targets and non-invasive diagnostic biomarkers for CP/CPPS patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Collins MM, Stafford RS, O’Leary MP, Barry MJ (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224–1228CrossRefPubMed Collins MM, Stafford RS, O’Leary MP, Barry MJ (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224–1228CrossRefPubMed
2.
Zurück zum Zitat Habermacher GM, Chason JT, Schaeffer AJ (2006) Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 57:195–206CrossRefPubMed Habermacher GM, Chason JT, Schaeffer AJ (2006) Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 57:195–206CrossRefPubMed
3.
Zurück zum Zitat Pena VN, Engel N, Gabrielson AT, Rabinowitz MJ, Herati AS (2021) Diagnostic and management strategies for patients with chronic prostatitis and chronic pelvic pain syndrome. Drugs Aging 38:845–886CrossRefPubMed Pena VN, Engel N, Gabrielson AT, Rabinowitz MJ, Herati AS (2021) Diagnostic and management strategies for patients with chronic prostatitis and chronic pelvic pain syndrome. Drugs Aging 38:845–886CrossRefPubMed
6.
Zurück zum Zitat Minerbi A, Shen S (2022) Gut microbiome in anesthesiology and pain medicine. Anesthesiology 137:93–108CrossRefPubMed Minerbi A, Shen S (2022) Gut microbiome in anesthesiology and pain medicine. Anesthesiology 137:93–108CrossRefPubMed
7.
Zurück zum Zitat Shoskes DA, Wang H, Polackwich AS, Tucky B, Altemus J, Eng C (2016) Analysis of gut microbiome reveals significant differences between men with chronic prostatitis/chronic pelvic pain syndrome and controls. J Urol 196:435–441CrossRefPubMed Shoskes DA, Wang H, Polackwich AS, Tucky B, Altemus J, Eng C (2016) Analysis of gut microbiome reveals significant differences between men with chronic prostatitis/chronic pelvic pain syndrome and controls. J Urol 196:435–441CrossRefPubMed
9.
Zurück zum Zitat Weersma RK, Zhernakova A, Fu J (2020) Interaction between drugs and the gut microbiome. Gut 69:1510–1519CrossRefPubMed Weersma RK, Zhernakova A, Fu J (2020) Interaction between drugs and the gut microbiome. Gut 69:1510–1519CrossRefPubMed
10.
Zurück zum Zitat Wu Y, Jiang H, Tan M, Lu X (2020) Screening for chronic prostatitis pathogens using high-throughput next-generation sequencing. Prostate 80:577–587CrossRefPubMedPubMedCentral Wu Y, Jiang H, Tan M, Lu X (2020) Screening for chronic prostatitis pathogens using high-throughput next-generation sequencing. Prostate 80:577–587CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Lv J, Wang J, Yu Y et al (2023) Alterations of gut microbiota are associated with blood pressure: a cross-sectional clinical trial in Northwestern China. J Transl Med 30(21):429CrossRef Lv J, Wang J, Yu Y et al (2023) Alterations of gut microbiota are associated with blood pressure: a cross-sectional clinical trial in Northwestern China. J Transl Med 30(21):429CrossRef
12.
Zurück zum Zitat Litwin MS, McNaughton-Collins M, Fowler FJ et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic prostatitis collaborative research network. J Urol 162:369–375CrossRefPubMed Litwin MS, McNaughton-Collins M, Fowler FJ et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic prostatitis collaborative research network. J Urol 162:369–375CrossRefPubMed
13.
Zurück zum Zitat Franzosa EA, Morgan XC, Segata N et al (2014) Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A 3(111):E2329–E2338 Franzosa EA, Morgan XC, Segata N et al (2014) Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A 3(111):E2329–E2338
17.
Zurück zum Zitat Murugesan S, Al KS (2023) Salivary microbiome and hypertension in the Qatari population. J Transl Med 8(21):454CrossRef Murugesan S, Al KS (2023) Salivary microbiome and hypertension in the Qatari population. J Transl Med 8(21):454CrossRef
18.
Zurück zum Zitat Yu S, Chen J, Zhao Y et al (2023) Oral-microbiome-derived signatures enable non-invasive diagnosis of laryngeal cancers. J Transl Med 5(21):438CrossRef Yu S, Chen J, Zhao Y et al (2023) Oral-microbiome-derived signatures enable non-invasive diagnosis of laryngeal cancers. J Transl Med 5(21):438CrossRef
19.
Zurück zum Zitat Shoskes DA, Altemus J, Polackwich AS, Tucky B, Wang H, Eng C (2016) The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92:26–32CrossRefPubMed Shoskes DA, Altemus J, Polackwich AS, Tucky B, Wang H, Eng C (2016) The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92:26–32CrossRefPubMed
20.
Zurück zum Zitat Mändar R, Punab M, Korrovits P et al (2017) Seminal microbiome in men with and without prostatitis. Int J Urol 24:211–216CrossRefPubMed Mändar R, Punab M, Korrovits P et al (2017) Seminal microbiome in men with and without prostatitis. Int J Urol 24:211–216CrossRefPubMed
21.
Zurück zum Zitat Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701–712CrossRefPubMed Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701–712CrossRefPubMed
22.
Zurück zum Zitat Montagnani M, Bottalico L, Potenza MA et al (2023) The crosstalk between gut microbiota and nervous system: a bidirectional interaction between microorganisms and metabolome. Int J Mol Sci 24:10322CrossRefPubMedPubMedCentral Montagnani M, Bottalico L, Potenza MA et al (2023) The crosstalk between gut microbiota and nervous system: a bidirectional interaction between microorganisms and metabolome. Int J Mol Sci 24:10322CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Krogius-Kurikka L, Lyra A, Malinen E et al (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9:95CrossRefPubMedPubMedCentral Krogius-Kurikka L, Lyra A, Malinen E et al (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9:95CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Saulnier DM, Riehle K, Mistretta T-A et al (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141:1782–1791CrossRefPubMed Saulnier DM, Riehle K, Mistretta T-A et al (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141:1782–1791CrossRefPubMed
25.
26.
Zurück zum Zitat Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A (2020) The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol 11:906CrossRefPubMedPubMedCentral Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A (2020) The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol 11:906CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Tan W, Zhang Q, Dong Z et al (2020) Phosphatidylcholine ameliorates LPS-induced systemic inflammation and cognitive impairments via mediating the gut-brain axis balance. J Agric Food Chem 16(68):14884–14895CrossRef Tan W, Zhang Q, Dong Z et al (2020) Phosphatidylcholine ameliorates LPS-induced systemic inflammation and cognitive impairments via mediating the gut-brain axis balance. J Agric Food Chem 16(68):14884–14895CrossRef
28.
Zurück zum Zitat Worby CJ, Schreiber HL, Straub TJ et al (2022) Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nat Microbiol 7:630–639CrossRefPubMedPubMedCentral Worby CJ, Schreiber HL, Straub TJ et al (2022) Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nat Microbiol 7:630–639CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Stanley D, Mason LJ, Mackin KE et al (2016) Translocation and dissemination of commensal bacteria in post-stroke infection. Nat Med 22:1277–1284CrossRefPubMed Stanley D, Mason LJ, Mackin KE et al (2016) Translocation and dissemination of commensal bacteria in post-stroke infection. Nat Med 22:1277–1284CrossRefPubMed
Metadaten
Titel
Gut microbiome in men with chronic prostatitis/chronic pelvic pain syndrome: profiling and its predictive significance
verfasst von
Shuai Wang
Maolin Zang
Xiaohui Yang
Linchen Lv
Lipeng Chen
Jianfeng Cui
Yaxiao Liu
Yangyang Xia
Nan Zhou
Zizhuo Yang
Yan Li
Benkang Shi
Publikationsdatum
09.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 11/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-023-04587-6

Weitere Artikel der Ausgabe 11/2023

World Journal of Urology 11/2023 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.